Why Alnylam’s Best Quarter Ever Didn’t Come With a Richer Valuation
2026 has marked a significant turning point in biotech capital markets, not just a small comeback.
Posts Tagged ‘Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)’
10 Best Growth Stocks With Highest Upside Potential
Growth stocks with large implied upside are getting another look as investors try to separate real earnings momentum from stocks that simply look cheap against analyst target ...
10 Best Fundamentally Strong Stocks to Buy for Long Term
On June 22, CNBC reported that the co-head of global investment strategy at JPMorgan Private Bank, Stephen Parker, on “Squawk Box,” commented that this year's stock market...
10 Most Promising Long-Term Stocks to Buy According to Analysts
On June 11, Emily Roland, Manulife John Hancock Investment Management, Co-Chief Investment Strategist, joined 'Squawk Box' on CNBC to describe the current market environment ...
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On
On May 27, Reuters reported that Biohub, a philanthropic venture formed by Meta CEO Mark Zuckerberg and Dr.
10 Most Promising Healthcare Stocks According to Wall Street Analysts
The US healthcare sector has trailed the broader market for three consecutive years, returning just 0.3% in 2023, 0.9% in 2024, and 12.5% in 2025.
15 High-Growth Large-Cap Stocks to Invest In Now
Expect US stocks to get an additional boost on a rotation into cyclical, economically sensitive industries that have lagged amid the US-Iran war.
12 Best Revenue Growth Stocks to Buy According to Wall Street Analysts
On May 22, Reuters reported that high-flying US stocks could face more ups and downs in the final days of a blowout corporate earnings season.
10 Best Aggressive Growth Stocks to Buy According to Wall Street Analysts
On May 13, Reuters reported that Morgan Stanley increased its annual target for the benchmark S&P 500 index.
8 Most Promising Biotech Stocks to Buy Now
On January 14, Reuters reported that investors foresee a comeback in the US biotech sector in 2026, with more IPO activity and stronger deal-making as legislative risks ease.
10 New Contenders for S&P 500 Index
Identifying new contenders for the S&P 500 has always attracted attention, as investors are constantly interested in the companies that may enter one of the most closely followed...
Truist Lowers PT on Alnylam Pharmaceuticals (ALNY) to $505 From $515
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the most oversold healthcare stocks to invest in. Truist cut the price target on Alnylam Pharmaceuticals Inc.
8 Most Oversold Healthcare Stocks to Invest In
Calling it a textbook classic move, he stated that we had a geopolitical shock and markets sold off hard before snapping right back up, making it the classic V shape.
10 Best Growth Stocks to Buy With Highest Upside Potential
On April 9, Tom Lee, Head of Research at Fundstrat, appeared on a CNBC Television interview to discuss market conditions as the war between the US and Iran had started to cool...
10 Best Future Stocks to Buy for the Next 5 Years
On March 25, Scott Chronert of Citi joined 'Closing Bell' on CNBC to discuss whether it is time to enter the market and if recent presidential actions have changed the market ...
Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best high growth healthcare stocks to buy now. Alnylam Pharmaceuticals Inc.
11 High Growth Healthcare Stocks to Buy Now
On March 26, Stephanie Link, Hightower chief investment strategist, appeared on CNBC's ‘Squawk Box’ to talk about the latest market trends, where investors can find opportunities...
12 Best Rebound Stocks to Buy Right Now
On March 20, oil prices rose again, shaking financial markets as prospects for a central bank interest rate cut in 2026 faded.
Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years.
10 Unstoppable Stocks to Buy and Hold for the Next 3 Years
Fundstrat's Tom Lee recently appeared on CNBC Television, highlighting that stocks declined mainly because of the software downturn and a general risk-off as gold surged.
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best NASDAQ growth stocks to buy for the next 2 years.
10 Best NASDAQ Growth Stocks to Buy for the Next 2 Years
On February 19, Tom Lee of Fundstrat and BitMine joined 'Closing Bell' on CNBC to talk about the state of the markets.
Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is among the best money-making stocks to buy right now.
11 Best Money-Making Stocks to Buy Right Now
In an environment marked by shifting rate expectations and growth volatility, investors remain focused on identifying companies capable of delivering sustainable earnings expansion...
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best upside stocks to invest in right now.
13 Best Upside Stocks to Invest In Right Now
On February 10, Sam Stovall, chief investment strategist at CFRA, and Tim Seymour, founder of Seymour Asset Management, appeared on CNBC’s 'Closing Bell Overtime' to discuss...
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the best healthcare stocks to buy for 2026.
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
11 Best Stocks to Buy for Investment
Following growing uncertainty in global markets amid heightened geopolitical tensions, the U.S. market rebounded this week.
12 Best US Stocks to Buy and Hold in 2026
On January 17, Ryan Detrick of Carson Group joined CNBC's 'Closing Bell Overtime' to talk about why he thinks the bull market still has room to run.
Alnylam (ALNY) Reports 238% Growth in Amvuttra Since February Launch, RBC Raises Price Target
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) ranks among the best biotech stocks to buy. RBC Capital maintained its Outperform rating for Alnylam Pharmaceuticals, Inc.
Wealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5%
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is among the most promising biotech stocks to buy according to hedge funds.
7 Most Promising Biotech Stocks to Buy According to Hedge Funds
If there’s one sector that is gaining popularity each day, it’s definitely the biotechnology market.
Alnylam’s AMVUTTRA Reduces GI Events in ATTR-CM Patients, According to New HELIOS-B Data
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best performing large cap stocks to buy.
Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance
Alnylam Pharmaceuticals, Inc.
12 Best Performing Large Cap Stocks to Buy
Earlier on August 29, Bob Keiser, Aspire Strategist Portfolios co-chief investment officer and senior market strategist, joined CNBC's 'Closing Bell Overtime' to talk about the...
14 Best Biotech Stocks to Buy Right Now
The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.
12 Best Performing Healthcare Stocks to Buy Right Now
Spending on healthcare in the US is predicted to hit $5.3 trillion this year, making it one of the largest in the world.
Alnylam Pharmaceuticals, Inc. (ALNY) Gets EU Nod for AMVUTTRA
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Alnylam Pharmaceuticals, Inc.
BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT
[caption id="attachment_1238247" align="aligncenter" width="1456"] A well-stocked pharmacy shelf full of the company's pharmaceuticals, nutraceuticals, over-the-counter medications...
Growth Stock Portfolio: 12 Companies with At Least 30% Annual Growth Rates
As we speak in mid-2025, the U.S. equity market continues to show modest gains. The NASDAQ exchange is up 4.44% YTD, while the broader market is advancing by 4.41% YTD.
The European Commission Approves Alnylam’s AMVUTTRA
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 13 Biotech Stocks with Huge Upside Potential.
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
Alnylam Pharmaceuticals (ALNY) Price Target Raised to $500 by H.C. Wainwright
On June 2, H.C. Wainwright’s Patrick Trucchio reiterated his Buy rating on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and raised his price target from $400 to $500.
12 Best Growth Stocks to Buy and Hold for the Long Term
The market closed last week mostly lower, however, the S&P 500 has been up more than 7% since April 11, indicating a returning positive sentiment.
10 Best Growth Stocks to Buy According to Billionaires
The stock market has been on a rollercoaster ride for the past few weeks as the sentiment has quickly shifted from post-election bullishness to being priced in for a slow-down...
10 Best Long Term Growth Stocks to Buy According to Billionaires
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated...
10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Hedge Fund Resource Center
